黄酮类化合物在防治糖尿病及其并发症方面的最新研究进展

焦晶晶;张英

中国药学杂志 ›› 2006, Vol. 41 ›› Issue (07) : 481-484.

中国药学杂志 ›› 2006, Vol. 41 ›› Issue (07) : 481-484.
综述

黄酮类化合物在防治糖尿病及其并发症方面的最新研究进展

  • 焦晶晶;张英
作者信息 +
文章历史 +

摘要

目的介绍黄酮类化合物在防治糖尿病及其并发症方面的研究概况。方法参阅近年来国内外文献,并进行整理、综述。结果黄酮类化合物是一类高药理活性的多酚类化合物,通过抗氧化、抑制α-葡萄糖苷酶和抗病毒感染等途径起到防治糖尿病的作用,并能抵抗血小板凝集、微血管病变和蛋白质非酶糖化等糖尿病并发症。结论进一步从天然产物中筛选黄酮类化合物,寻找其作为防治糖尿病及其并发症研究开发的先导化合物,具有重要的理论与应用价值。

关键词

黄酮类化合物 / 糖尿病 / 并发症 / 降血糖

引用本文

导出引用
焦晶晶;张英. 黄酮类化合物在防治糖尿病及其并发症方面的最新研究进展[J]. 中国药学杂志, 2006, 41(07): 481-484

参考文献

[1] YAO X S. Nature Drug Chemistry[M] . 2nd ed.Beijing: People’s Medical Publishing House, 1997: 277-298. [2] ZHANG Y. Natural functional extract of bamboo leaves——bamboo leaf anthoxanthin[J] .China Food Addtives(中国食品添加剂), 2002, (3): 54-58. [3] ANILA L, VIJAYALAKSHMI N R. Antioxidant action of flavonoids from mangifera indica and emblica officinalis in hypercholesterolemic rats[J] . Food Chem, 2003, 83(4): 569-574. [4] WU J H, WANG X H, YI Y H, et al. A potent anti-HIV chalcone and flavonoids from genus desmos[J] . Bioorg Med Chem Lett, 2003, 13(10): 1813-1815. [5] CANDLISH J K, DAS N P. Antioxidants in food and chronic degenerative diseases[J] . Biomed Environ Sci, 1996, 9(2-3): 117-123. [6] MAHMOOD V, MINA H, MOHAMMAD V. Antidiabetic effects of quercetin in streptozocin-induced diabetic rats[J] . Comp Biochem Phys C, 2003, 135(3): 357-364. [7] VEDAVANAM K, SRIJAYANTA S, O'REILLY J, et al. Antioxidant action and potential antidiabetic properties of an isoflavonoid-containing soyabean phytochemical extract (SPE)[J] . Phytother Res, 1999, 13(7): 601-608. [8] YOKOZAWA T, KIM H Y, CHO E J, et al. Antioxidant effects of isorhamnetin 3,7-di-O-β-D-glucopyranoside isolated from mustard leaf (Brassica juncea) in rats with streptozotocin-induced diabetes[J] . J Agric Food Chem, 2002, 50(19): 5490-5495. [9] GUILLOT R, OGNEVA V, HADJIISKY P, et al. Effect of long-term treatment with a purified micronized flavonoid fraction on pancreatic mononuclear cell infiltration in diabetic BB rats[J] . Pancreas, 1998, 17(3): 301-308. [10] WATANABE J, KAWABATA J, KURIHARA H, et al. Isolation and identification of α-glucosidase inhibitors from tochucha (Eucommia ulmoides)[J] . Biosci Biotechnol Biochem, 1997, 61(1): 177-178. [11] QUAN J S, YIN X Z, KANAZAWA T, et al. Inhibition of alpha-glucosidase and alpha-amylase by soybean isoflavonoids[J] . J Med Sci Yanbian Univ(延边大学医学学报), 2001, 24(4): 239-242. [12] WALTNER L M, WANG X L, LAW B K, et al. Epigallocatechin gallate, a constituent of green tea, represses hepatic glucose production[J] . J Biol Chem, 2002, 277(38): 34933-34940. [13] HNATYSZYN O, MINO J, FERRARO G, et al. The hypoglycemic effect of phyllanthus sellowianus fractions in streptozotocin-induced diabetic mice[J] . Phytomedicine, 2002, 9(6): 556-559. [14] LEAN M E, NOROOZI M, KELLY I, et al. Dietary flavonols protect diabetic human lymphocytes against oxidative damage to DNA[J] . Diabetes, 1999, 48(1): 176-181. [15] LI H J, REN H Y, YUAN H Q. Recent situation on antidiabetic treatment by small or single prescription[J] . J Shandong Coll Tridit Chin Med(山东中医学院学报), 1996, 20(5): 353-356. [16] QUAN J S, TANAKA M, KANAZAWA T. Inhibitory effect of soybean isoflavones on platelet aggregation[J] . J Med Sci Yanbian Univ, 2002, 25(2): 94-96. [17] KIMURA Y, OKUDA H, OGITA Z. Effects of flavonoids isolated from scutellariae radix on fibrinolytic system induced by trypsin in human umbilical vein endothelial cells[J] . J Nat Prod, 1997, 60(6): 598-601. [18] CLAUSEN P, JACOBSEN P, ROSSING K, et al. Plasma concentrations of VCAM-1 and ICAM-1 are elevated in patients with Type 1 diabetes mellitus with microalbuminuria and overt nephropathy[J] . Diabetic Med, 2000, 17(9): 644-649. [19] ASGARY S, NADERI G H, SARRAFZADEGAN N, et al. The effect of flavonoids on the prevention of insulin glycosylation[J] . Atherosclerosis, 1998, 136 (Suppl 1): 566. [20] WANG J, CHEN M, CAO Y, et al. Effect of kakoneina and gingko flavone on protein nonenzymatic glycosylation[J] . Pharmcol Clin Chin Mater Med(中药药理与临床), 2000, 16(1): 13-14. [21] SIMA A A F, SUGIMOTO K. Experimental diabetic neuropathy: an update[J] . Diabetologia, 1999, 42(2): 773-788. [22] NAGASAWA T, TABATA N, ITO Y, et al. Suppression of early and advanced glycation by dietary water-soluble rutin derivative in diabetic rats[J] . Int Congress Series, 2002, 1245(1-2): 403-405. [23] CAMIRE M E, DOUGHERTY M P, PETRASH J M. Inhibition of aldose reductase by fruit anthocyanins[J] . Public Health Nutr, 2000, 3(2): 529-530. [24] MOROTA T, TAKEDA H, SASAKI H, et al. Aldose reductose inhibitors containing phenols of caesalpinia sappan[J] . CA, 1991, 114: 235041a. [25] NISHIMURA H, KUBO M, TAKEDA H, et al. Flavone C-glucosides for treatment of diseased associated with diabetes[J] . CA, 1992, 117: 76465. [26] GORIO A, DONADONI M L, FINCO C, et al. Alterations of protein mono-ADP-ribosylation and diabetic neuropathy: a novel pharmacological approach[J] . Eur J Pharm, 1996, 311(1): 21-28. [27] YANG H J, LIU L C, HUANG H L. Research development on anti-diabetes by active components of Chinese traditional herbs[J] . Chin J Inf Tradit Chin Med(中国中医药信息杂志), 2005, 12(2): 92-93.

基金

浙江省自然科学基金重点资助项目(ZA0218)

Accesses

Citation

Detail

段落导航
相关文章

/